DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 1 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,107,000 | +145.2% | 203,680 | +353.8% | 0.04% | +133.3% |
| Q2 2021 | $1,675,000 | +82.1% | 44,885 | +24.7% | 0.02% | +63.6% |
| Q1 2021 | $920,000 | +178.8% | 36,002 | +141.0% | 0.01% | +175.0% |
| Q4 2020 | $330,000 | -69.3% | 14,938 | -75.0% | 0.00% | -80.0% |
| Q3 2020 | $1,075,000 | -9.7% | 59,744 | +27.5% | 0.02% | +25.0% |
| Q2 2020 | $1,190,000 | +438.5% | 46,864 | +367.0% | 0.02% | +220.0% |
| Q4 2019 | $221,000 | -66.5% | 10,036 | -78.1% | 0.01% | -73.7% |
| Q3 2019 | $659,000 | -74.4% | 45,900 | -72.0% | 0.02% | -79.1% |
| Q2 2019 | $2,578,000 | +180.8% | 163,700 | +90.6% | 0.09% | +160.0% |
| Q4 2018 | $918,000 | -78.4% | 85,900 | -69.1% | 0.04% | -81.5% |
| Q3 2018 | $4,247,000 | +670.8% | 278,300 | +518.4% | 0.19% | +530.0% |
| Q2 2018 | $551,000 | -40.2% | 45,000 | -53.3% | 0.03% | -56.5% |
| Q1 2018 | $921,000 | – | 96,268 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $103,638,000 | 10.86% |
| Aquilo Capital Management, LLC | 1,454,686 | $36,949,000 | 7.45% |
| RTW INVESTMENTS, LP | 7,152,918 | $181,684,000 | 5.11% |
| EcoR1 Capital, LLC | 2,721,993 | $69,139,000 | 5.11% |
| BRIDGER MANAGEMENT, LLC | 1,473,568 | $37,429,000 | 3.47% |
| DAFNA Capital Management LLC | 454,236 | $11,538,000 | 3.33% |
| Parkman Healthcare Partners LLC | 300,805 | $7,640,000 | 2.15% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $4,318,000 | 1.25% |
| Integral Health Asset Management, LLC | 110,000 | $2,794,000 | 0.84% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,013,087 | $25,732,000 | 0.63% |